TY  - JOUR
T1  - AS trials advance for a malaria vaccine, policy makers urged to plan for its use
AU  - Voelker R
Y1  - 2010/12/01
N1  - 10.1001/jama.304.21.2348
JO  - JAMA
SP  - 2348
EP  - 2348
VL  - 304
IS  - 21
N2  - 
“After decades of research and tens of millions of dollars invested  . . .  it would be scandalous if this vaccine just sits on the shelf,” said Yvette Collymore, MA, of the nonprofit PATH Malaria Vaccine Initiative (MVI), during a recent Washington, DC, conference. 

SN  - 0098-7484
M3  - doi: 10.1001/jama.304.21.2348
UR  - http://dx.doi.org/10.1001/jama.304.21.2348
ER  -